A detailed history of Summit Financial, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Summit Financial, LLC holds 49,953 shares of ABT stock, worth $5.71 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
49,953
Previous 46,668 7.04%
Holding current value
$5.71 Million
Previous $4.85 Million 17.45%
% of portfolio
0.22%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $328,729 - $388,057
3,285 Added 7.04%
49,953 $5.7 Million
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $1.96 Million - $2.18 Million
19,428 Added 71.32%
46,668 $4.85 Million
Q1 2024

Apr 24, 2024

BUY
$109.52 - $120.96 $67,026 - $74,027
612 Added 2.3%
27,240 $3.1 Million
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $48,973 - $59,947
-543 Reduced 2.0%
26,628 $2.93 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $250,097 - $300,075
2,618 Added 10.66%
27,171 $2.63 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $1.58 Million - $1.76 Million
15,674 Added 176.53%
24,553 $2.68 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $58,794 - $69,204
-607 Reduced 6.4%
8,879 $899,000
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $537,849 - $630,980
-5,658 Reduced 37.36%
9,486 $1.04 Million
Q3 2022

Nov 15, 2022

SELL
$96.76 - $112.03 $103,533 - $119,872
-1,070 Reduced 6.6%
15,144 $1.47 Billion
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $26,844 - $32,446
-263 Reduced 1.6%
16,214 $1.76 Million
Q1 2022

May 10, 2022

BUY
$114.02 - $139.04 $303,635 - $370,263
2,663 Added 19.28%
16,477 $1.95 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $340,929 - $417,448
2,951 Added 27.17%
13,814 $1.94 Million
Q3 2021

Nov 08, 2021

BUY
$116.66 - $129.06 $1.27 Million - $1.4 Million
10,863 New
10,863 $1.28 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.